Take a fresh look at your lifestyle.

Pfizer and BioNTech celebrate the approval of their vaccines against Covid


Hope has returned to investors as fear of outbreaks is gone. The reason? The United States Medicines Agency (FDA) has granted this Monday a "fast track" to two experimental vaccines from BioNTech and Pfizer.

Both companies have celebrated it with enthusiasm in the parquet. The first has advanced 4% while the second has been unmarked with advances close to 10%. The vaccines they are developing together are among the favorites to win the race in the search for a cure against Covid-19.

"The FDA decision means a Important milestone in efforts to develop a safe and effective vaccine Against SARS-CoV-2, "said Peter Honig, Pfizer Senior Vice President, Global Regulatory Affairs.

The news has not only been well received in the price of both companies, optimism has been seen in the main squares around the world. The indices of the Old Continent have closed the day with strong increases, in fact the least bullish has been the Italian stock market and has closed with an advance of more than 1%.

Strong increases that have marked much of the day in the United States. After a strongly bullish start, Wall Street has finally closed with the red numbers as protagonists. The performance of the S&P 500 has stood out, which has reached levels of mid-February, although it has finally decreased by 0.93%.

. (tagsToTranslate) Pfizer (t) BioNTech (t) celebrated (t) bag (t) seen (t) good (t) vaccines (t) against (t) Covid (t) Category: All (t) Category: Market Report (t) Category: Company News (t) Category: US Report (t) Category: International News (t) Category: Pulses (t) Category: Pulses USA (t) Category: Market Pulse (t) Category: Sectorial: Health Technology (t) mostread_empresas (t) mostread_internacional

Leave A Reply

Your email address will not be published.